Skin patch from donor helps patient detect lung rejection

Innovative biomedical research demonstrates how donor-derived skin grafts can serve as biological markers for detecting organ rejection. This breakthrough technique involves transplanting compatible skin tissue that exhibits immune response signals identical to the primary organ, enabling physicians to monitor rejection symptoms non-invasively. The approach offers patients a safer alternative to invasive biopsies, improving early detection and treatment outcomes for lung transplant recipients.